Pancreatic Cancer Research

ResearcherUniversity of Southern CaliforniaActive in the last 2 years

Diana L. Hanna

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2681-5032; OpenAlex author ID A5102929792. Sources: ClinicalTrials.gov.

Their work

Papers
5 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2021: 1 trial · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers

Papers 5

  1. A randomized phase II trial of gemcitabine, nab-paclitaxel, cisplatin with or without a medically supervised ketogenic diet for patients with metastatic pancre… Co-author DOI 10.1002/cncr.70343↗
  2. Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer". Co-author DOI 10.1002/cncr.70510↗
  3. Emerging precision therapeutics for pancreatic ductal adenocarcinoma: KRAS and beyond. Last author DOI 10.1177/17588359261432058↗
  4. Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRAS G12D-mutated pancreatic cancer. Co-author DOI 10.1186/s40164-025-00669-w↗
  5. Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma. Co-author DOI 10.1093/oncolo/oyae155↗

Trials 1

  1. CMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except Melanoma Principal investigator NCT04387071↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gayle Jameson · 2 shared papers, 2026 · strength 0.51
  2. Drew Warren Rasco · 2 shared papers, 2026 · strength 0.51
  3. Joshua D. Rabinowitz · 2 shared papers, 2026 · strength 0.51
  4. Erkut Hasan Borazanci · 2 shared papers, 2026 · strength 0.51
  5. Daniel D. Von Hoff · 2 shared papers, 2026 · strength 0.51
  6. Ani Misirian · 1 shared paper, 2026 · strength 0.50
  7. Derek Cridebring · 1 shared paper, 2026 · strength 0.22
  8. Richard C. Frank · 1 shared paper, 2026 · strength 0.22
  9. Angela Tatiana Alistar · 1 shared paper, 2026 · strength 0.22
  10. Huynh Le Cao · 1 shared paper, 2025 · strength 0.19
  11. Jeffrey Xiao · 1 shared paper, 2025 · strength 0.19
  12. Yi Xu · 1 shared paper, 2025 · strength 0.19
  13. Sreenivasa Rao Chandana · 1 shared paper, 2024 · strength 0.15
  14. Naomi H. Fei · 1 shared paper, 2024 · strength 0.15
  15. Abdullah Esmail · 1 shared paper, 2024 · strength 0.15
  16. Farshid Dayyani · 1 shared paper, 2024 · strength 0.15
  17. Pashtoon Murtaza Kasi · 1 shared paper, 2024 · strength 0.15
  18. Maen Abdelrahim · 1 shared paper, 2024 · strength 0.15
  19. Midhun Malla · 1 shared paper, 2024 · strength 0.15
  20. Michael Cecchini · 1 shared paper, 2024 · strength 0.15
  21. Giby V. George · 1 shared paper, 2024 · strength 0.15
  22. Anup Kasi · 1 shared paper, 2024 · strength 0.15
  23. Jill Lacy · 1 shared paper, 2024 · strength 0.15
  24. Gregory P. Botta · 1 shared paper, 2024 · strength 0.15
  25. Adham Adel Jurdi · 1 shared paper, 2024 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.